In addition to inhibiting the resistance of ovarian cancer cells to cisplatin, propofol can also enhance the killing effect of paclitaxel on ovarian cancer cells by inhibiting the expression of Slug (Wang et al., 2013). This evidence concerns the gene SNAI2 and ovarian carcinoma.